Pharma & Biotech News , from our Global Correspondents
Refine Search
Pharmaceutical
The All-Russian Union of Patients (VSP) has called on Russia’s Deputy Prime Minister, Tatyana Golikova, to expand the list of drugs that are the subject of public procurements in the country in order to avoid a shortage of certain categories of drugs in the domestic market, The Pharma Letter’s local correspondent reports.. 10 April 2025
Pharmaceutical
The Russian pharmaceutical market grew by 10% in value terms to 2.85 trillion roubles ($85 billion) in 2024, which was mainly due to the growth of it commercial segment, where the growth of sales was equivalent to 13.8%. 9 April 2025
Pharmaceutical
Neuromyelitis optica spectrum disorder (NMOSD) – also known as neuromyelitis optica (NMO) and Devic’s disease – is a rare, chronic autoimmune condition that affects the central nervous system (CNS), especially the optic nerve and spinal cord. The estimated prevalence is 1 to 10 per 100,000 individuals worldwide, with the condition more common among Hispanic, Black and Asian populations. 7 April 2025
Pharmaceutical
The Chinese government is contemplating a new drug reimbursement category called category C to make commercial insurance companies a major payer. If the new category is introduced, it is expected to significantly accelerate China’s innovation, said speakers at the BIOCHINA event held in Suzhou. 5 April 2025
Generics
Russian drug manufacturers are eliminating global players from the domestic insulin market, as their sales are steadily growing, The Pharma Letter’s local correspondent reports. 26 March 2025
Generics
Russia may face a new wave of drugs’ shortages, particularly those, which are used for the treatment of rare diseases, as sanctions continue to bite, reports The Pharma Letter’s local correspondent. 25 March 2025
Biotechnology
China's burgeoning biotech R&D capabilities are attracting increasing international attention, with non-Western countries actively seeking partnerships. At the BIOCHINA event in Suzhou on March 13, representatives from South Korean and Russian biotechs expressed strong interest in collaborating with Chinese counterparts. 21 March 2025
Generics
The Russian drugmaker Axelpharm will continue sales of its drug axitinib, which is used in kidney cancer therapy and is a generic of version of US pharma giant Pfizer’s Inlyta, reports The Pharma Letter’s local correspondent.
drug of the US Pfizer. 18 March 2025
Pharmaceutical
Hours after the swearing-in of the Secretary of Health and Human Services, Robert F Kennedy Jr (RFK), President Donald Trump issued an executive order establishing the Make America Healthy Again Commission (MAHA). 17 March 2025
Pharmaceutical
Sales of antidepressants in Russia during the period of January-February 2025 amounted to 2.8 billion roubles ($30 million) with a total of 3.2 million packages sold, which became a record figure for the country in the last five years, reports The Pharma Letter’s local correspondent. 17 March 2025
Pharmaceutical
The Russian Ministry of Industry and Trade has developed criteria for including drugs in the list of strategically important medicines – a measure that will provide an opportunity for their manufacturers to apply for new government support measures, reports The Pharma Letter’s local correspondent. 11 March 2025
Pharmaceutical
Leading pharmaceutical associations in Russia have called on the government to postpone the introduction of new procurement rules that will give preference to drugs completely produced in Russia in state tenders. 5 March 2025
Pharmaceutical
Russia plans to increase procurements of drugs against rare diseases despite the current tough business environment and maintaining sanctions pressure, reports The Pharma Letter’s local correspondent. 4 March 2025
Generics
Even as the spectre of tariffs looms over the pharmaceutical trade between India and the USA, presenting a complex scenario with potential repercussions for both regions, its implementation would necessitate a rapid recalibration of supply chains and pricing strategies, reports The Pharma Letter’s India correspondent. 3 March 2025
Pharmaceutical
Encephalitis is a complex and often devastating condition that can leave lasting neurological damage in survivors. Despite advancements in medical science, effective treatments remain limited, and many cases still go undiagnosed or misattributed. 28 February 2025
Generics
Israeli drug manufacturer Teva Pharmaceutical Industries has resumed the deliveries of the scarce epilepsy drug Finlepsin retard (carbamazepine) to the Russian market, which is aimed to alleviate shortages of the product, reports The Pharma Letter’s local correspondent. 28 February 2025
Pharmaceutical
The government of Ukraine plans to increase public procurements of drugs this year and to make them more affordable for local population despite the current tough business environment in the country and the ongoing war with Russia, reports The Pharma Letter’s local correspondent. 27 February 2025
Pharmaceutical
India's pharmaceutical market is witnessing a surge in new drug launches, particularly in the oncology segment, fueled by a rising cancer burden and demand for cutting-edge treatments. Leading the charge are big domestic pharma spearheading the launch of breakthrough oncology drugs. 23 February 2025
Pharmaceutical
Binnopharm Group, one of Russia’s leading drugmakers, which is controlled by the Russian financial conglomerate AFK Sistema, will begin selling two hormonal drugs in Russia in May 2025, and will consider localizing their production in the future, reports The Pharma Letter’s local correspondent. 21 February 2025
Pharmaceutical
The All-Russian Union of Patients (VSP) has called on Russia’s Deputy Prime Minister, Tatyana Golikova, to expand the list of drugs that are the subject of public procurements in the country in order to avoid a shortage of certain categories of drugs in the domestic market, The Pharma Letter’s local correspondent reports.. 10 April 2025
Pharmaceutical
The Russian pharmaceutical market grew by 10% in value terms to 2.85 trillion roubles ($85 billion) in 2024, which was mainly due to the growth of it commercial segment, where the growth of sales was equivalent to 13.8%. 9 April 2025
Pharmaceutical
Neuromyelitis optica spectrum disorder (NMOSD) – also known as neuromyelitis optica (NMO) and Devic’s disease – is a rare, chronic autoimmune condition that affects the central nervous system (CNS), especially the optic nerve and spinal cord. The estimated prevalence is 1 to 10 per 100,000 individuals worldwide, with the condition more common among Hispanic, Black and Asian populations. 7 April 2025
Pharmaceutical
The Chinese government is contemplating a new drug reimbursement category called category C to make commercial insurance companies a major payer. If the new category is introduced, it is expected to significantly accelerate China’s innovation, said speakers at the BIOCHINA event held in Suzhou. 5 April 2025
Generics
Russian drug manufacturers are eliminating global players from the domestic insulin market, as their sales are steadily growing, The Pharma Letter’s local correspondent reports. 26 March 2025
Generics
Russia may face a new wave of drugs’ shortages, particularly those, which are used for the treatment of rare diseases, as sanctions continue to bite, reports The Pharma Letter’s local correspondent. 25 March 2025
Biotechnology
China's burgeoning biotech R&D capabilities are attracting increasing international attention, with non-Western countries actively seeking partnerships. At the BIOCHINA event in Suzhou on March 13, representatives from South Korean and Russian biotechs expressed strong interest in collaborating with Chinese counterparts. 21 March 2025
Generics
The Russian drugmaker Axelpharm will continue sales of its drug axitinib, which is used in kidney cancer therapy and is a generic of version of US pharma giant Pfizer’s Inlyta, reports The Pharma Letter’s local correspondent.
drug of the US Pfizer. 18 March 2025
Pharmaceutical
Hours after the swearing-in of the Secretary of Health and Human Services, Robert F Kennedy Jr (RFK), President Donald Trump issued an executive order establishing the Make America Healthy Again Commission (MAHA). 17 March 2025
Pharmaceutical
Sales of antidepressants in Russia during the period of January-February 2025 amounted to 2.8 billion roubles ($30 million) with a total of 3.2 million packages sold, which became a record figure for the country in the last five years, reports The Pharma Letter’s local correspondent. 17 March 2025
Pharmaceutical
The Russian Ministry of Industry and Trade has developed criteria for including drugs in the list of strategically important medicines – a measure that will provide an opportunity for their manufacturers to apply for new government support measures, reports The Pharma Letter’s local correspondent. 11 March 2025
Pharmaceutical
Leading pharmaceutical associations in Russia have called on the government to postpone the introduction of new procurement rules that will give preference to drugs completely produced in Russia in state tenders. 5 March 2025
Pharmaceutical
Russia plans to increase procurements of drugs against rare diseases despite the current tough business environment and maintaining sanctions pressure, reports The Pharma Letter’s local correspondent. 4 March 2025
Generics
Even as the spectre of tariffs looms over the pharmaceutical trade between India and the USA, presenting a complex scenario with potential repercussions for both regions, its implementation would necessitate a rapid recalibration of supply chains and pricing strategies, reports The Pharma Letter’s India correspondent. 3 March 2025
Pharmaceutical
Encephalitis is a complex and often devastating condition that can leave lasting neurological damage in survivors. Despite advancements in medical science, effective treatments remain limited, and many cases still go undiagnosed or misattributed. 28 February 2025
Generics
Israeli drug manufacturer Teva Pharmaceutical Industries has resumed the deliveries of the scarce epilepsy drug Finlepsin retard (carbamazepine) to the Russian market, which is aimed to alleviate shortages of the product, reports The Pharma Letter’s local correspondent. 28 February 2025
Pharmaceutical
The government of Ukraine plans to increase public procurements of drugs this year and to make them more affordable for local population despite the current tough business environment in the country and the ongoing war with Russia, reports The Pharma Letter’s local correspondent. 27 February 2025
Pharmaceutical
India's pharmaceutical market is witnessing a surge in new drug launches, particularly in the oncology segment, fueled by a rising cancer burden and demand for cutting-edge treatments. Leading the charge are big domestic pharma spearheading the launch of breakthrough oncology drugs. 23 February 2025
Pharmaceutical
Binnopharm Group, one of Russia’s leading drugmakers, which is controlled by the Russian financial conglomerate AFK Sistema, will begin selling two hormonal drugs in Russia in May 2025, and will consider localizing their production in the future, reports The Pharma Letter’s local correspondent. 21 February 2025
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze